DekaBank Deutsche Girozentrale
NGM

DekaBank Deutsche Girozentrale’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-25,700
Closed -$317K – 1415
2022
Q3 		$317K Hold
25,700
– – ﹤0.01% 1137
2022
Q2 		$333K Hold
25,700
– – ﹤0.01% 1095
2022
Q1 		$400K Buy
25,700
+2,300
+10% +$35.9K ﹤0.01% 1100
2021
Q4 		$401K Sell
23,400
-23,700
-50% -$455K ﹤0.01% 1148
2021
Q3 		$944K Hold
47,100
– – ﹤0.01% 916
2021
Q2 		$933K Hold
47,100
– – ﹤0.01% 927
2021
Q1 		$1.29M Buy
47,100
+26,000
+123% +$728K ﹤0.01% 835
2020
Q4 		$654K Sell
21,100
-1,100
-5% -$24.1K ﹤0.01% 967
2020
Q3 		$351K Buy
+22,200
New +$405K ﹤0.01% 983

Other funds holding NGM

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DekaBank Deutsche Girozentrale's NGM Position: Q4 2022 in Review

DekaBank Deutsche Girozentrale sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q4 2022, closing a stake of 25,700 shares — an estimated $317K sold.

DekaBank Deutsche Girozentrale first reported a position in NGM in Q3 2020 and held it in 9 quarters. The position peaked at $1.29M in Q1 2021. 125 funds tracked by Wall St. Rank hold NGM as of Q4 2022.

  • DekaBank Deutsche Girozentrale reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 25,700 NGM Biopharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $317K.
  • DekaBank Deutsche Girozentrale first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
  • DekaBank Deutsche Girozentrale's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $1.29M in Q1 2021.
  • 125 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2022, filed 1 Feb 2023.